The nightly ledger

Stock catalysts from the latest SEC filings

Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price. For 8-K filing alerts, follow a company and turn on filing emails.

By event type: Acquisitions · Major contracts

Seven-day window, 6 weeks back · Material filings: 95 · All filings: 232

Material

Tuesday 6 Oct6 filings read · 6 material

  • 8-KFiled 6 Oct 2026All industries

    IES Holdings, Inc.IESC

    8-K · Items 1.01, 2.01 — Material agreement

    IES Holdings completed acquisition of DBM Global for ~$691M, adding structural steel fabrication/erection as new business line. DBM Global generated ~$1.5B revenue (12M ended June 2026) and brings ~4,000 employees. Funded via $545M cash and $146M stock; credit facility expanded to $700M.

    News flow: Balanced 54 → Balanced 58Recognition: Balanced 63 → Balanced 58Value: Watch 44 → Balanced 55Gap Very high · 51 → Very high · 87

    The filings read more positively.

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 6 Oct 2026Software / SaaS

    Clarivate PLCCLVT

    8-K · Items 2.01, 5.02, 8.01 — Acquisition or disposal of assets

    Clarivate completed sale of Life Sciences & Healthcare segment to Altaris for $600M ($500M cash + $75M note + $25M deferred). Proceeds to reduce debt and strengthen balance sheet. Company now focused on Academia & Government and Intellectual Property segments.

    News flow: Balanced 49 → Balanced 54Gap Low · 0 → Very high · 75

    The filings read more positively.

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 6 Oct 2026Industrials

    Biolife Solutions IncBLFS

    8-K · Items 2.01, 3.01, 3.03, 5.01, 5.02 — Acquisition or disposal of assets

    BioLife Solutions completed its acquisition by Repligen on October 6, 2026. BioLife shareholders received 0.1442 Repligen shares plus $11.25 cash per share. BioLife ceased to exist as a separate entity and delisted from Nasdaq.

    No notable change in AIR's read.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 6 Oct 2026Biotech

    Repligen CorpRGEN

    8-K · Item 2.01 — Acquisition or disposal of assets

    Repligen completed acquisition of BioLife Solutions on October 6, 2026. BioLife's biopreservation media and cell therapy products expand Repligen's presence in rapidly growing cell therapy market with high-margin consumables and recurring revenue.

    News flow: Balanced 52 → Balanced 55Gap Medium · 13 → High · 31

    The filings read more positively.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 6 Oct 2026All industries

    Brandywine Realty TrustBDN

    8-K · Item 2.01 — Acquisition or disposal of assets

    Brandywine completed sale of 441,000 sq ft Philadelphia office building (3151 Market Street) for $240M gross proceeds ($233.7M net), with concurrent $60.2M debt repayment. Pro forma shows reduced asset base and interest expense.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material

Monday 5 Oct7 filings read · 7 material

  • 8-KFiled 5 Oct 2026Semiconductors

    Qorvo, Inc.QRVO

    8-K · Items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02 — Material agreement terminated

    Qorvo completed its merger with Skyworks Solutions on October 5, 2026. Qorvo shareholders received 0.960 Skyworks shares plus $32.50 cash per share. Qorvo is now a wholly owned subsidiary of Skyworks and ceased public trading.

    No notable change in AIR's read.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Oct 2026Semiconductors

    Skyworks Solutions, Inc.SWKS

    8-K · Items 2.01, 5.02, 8.01 — Acquisition or disposal of assets

    Skyworks completed acquisition of Qorvo on October 5, 2026. Qorvo shareholders received 0.960 Skyworks shares plus $32.50 cash per share. Skyworks financed $2B cash portion via debt issuance in August 2026. Board expanded to 11 directors with 3 Qorvo designees.

    News flow: Balanced 51 → Balanced 56Gap Low · 3 → Medium · 22

    The filings read more positively.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Oct 2026All industries

    Geo Group IncGEO

    8-K · Items 1.01, 2.01, 8.01 — Material agreement

    GEO completed sale of three Adelanto, California ICE facilities (2,644 beds) to DHS for $950M gross ($705M net). Company retains service contracts through 2034 and increased share repurchase authorization to $1.25B.

    News flow: Balanced 52 → Balanced 57Gap Medium · 22 → Very high · 56

    The filings read more positively.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Oct 2026All industries

    Matador Resources CoMTDR

    8-K · Item 2.01 — Acquisition or disposal of assets

    Matador Resources completed acquisition of Paloma Permian for ~$1.255 billion in cash. Target owns proved undeveloped acreage and producing oil/gas properties in New Mexico's Permian Basin.

    News flow: Balanced 54 → Balanced 57Gap Very high · 69 → Very high · 88

    The filings read more positively.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Oct 2026All industries

    Chiron Real Estate Inc.XRN

    8-K · Items 2.01, 2.03 — Acquisition or disposal of assets

    Chiron Real Estate closed acquisition of The Pinnacle North Bethesda senior housing community for $173.2M on October 1, 2026. Funded via cash and $171M credit facility draw. Third-party operator Greystone will manage day-to-day operations.

    News flow: first measured — Balanced 54Gap first measured: Very high · 72

    AIR measured this for the first time; no change to report.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Oct 2026Biotech

    Harrow, Inc.HROW

    8-K · Items 1.01, 2.01 — Material agreement

    Harrow completed acquisition of TYRVAYA, an FDA-approved nasal spray for dry eye disease, from Viatris for $30M upfront plus up to $70M in milestone payments. Acquisition expands dry eye portfolio alongside VEVYE and adds ~40 commercial personnel.

    News flow: Balanced 54 → Balanced 58Gap Very high · 75 → Very high · 95

    The filings read more positively.

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material

Research, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.